Entera Bio Regains Compliance with Nasdaq Listing Requirements
23 mars 2023 09h27 HE
|
Entera Bio Ltd.
JERUSALEM, March 23, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced...